The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease

[1]  M. Srichai,et al.  Takayasu's Arteritis , 2012 .

[2]  G. Hunder,et al.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. , 2010, Arthritis and rheumatism.

[3]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[4]  E. Henze,et al.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study , 2004, Annals of the rheumatic diseases.

[5]  A. Al-nahhas,et al.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  P. Merkel,et al.  Diagnostic imaging in Takayasu arteritis , 2004, Current opinion in rheumatology.

[7]  M. Brodmann,et al.  The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. , 2003, Rheumatology.

[8]  L. Mortelmans,et al.  Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  M. Brodmann,et al.  Positron emission tomography reveals extended thoracic and abdominal peri-aortitis. , 2003, Vascular medicine.

[10]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  A. Al-nahhas,et al.  Takayasu’s arteritis: management of left main stem stenosis , 2003, Heart.

[12]  R. Gasser,et al.  Generalized Large Vessel Arteritis Visualized by 18Fluorodeoxyglucose-Positron Emission Tomography , 2003 .

[13]  E. Grabbe,et al.  Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis , 2003, European Radiology.

[14]  M. Vinceti,et al.  Is Duplex Ultrasonography Useful for the Diagnosis of Giant-Cell Arteritis? , 2002, Annals of Internal Medicine.

[15]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[16]  Richard D. White,et al.  Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. , 2002, Arthritis and rheumatism.

[17]  E. Chilvers,et al.  Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  D. Blockmans.  Utility of imaging studies in assessment of vascular inflammation. , 2002, Cleveland Clinic journal of medicine.

[19]  L. Mortelmans,et al.  Positron emission tomography can reveal abdominal periaortitis. , 2002, Clinical nuclear medicine.

[20]  U. Müller-Ladner,et al.  Clinical image: occult large vessel vasculitis diagnosed by PET imaging , 2001, Rheumatology International.

[21]  S. Larson,et al.  Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. , 2001, Archives of internal medicine.

[22]  A. Alavi,et al.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.

[23]  P. Ott.  Images in cardiovascular medicine: Unusual ECG. , 2001 .

[24]  C. Van de Wiele,et al.  Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography. , 2000, Clinical nuclear medicine.

[25]  A. Maes,et al.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. , 2000, The American journal of medicine.

[26]  J. Nuyts,et al.  New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. , 1999, Rheumatology.

[27]  B. Chiu,et al.  Aortic dissection in giant-cell arteritis. , 1995, Seminars in arthritis and rheumatism.

[28]  G. Hunder,et al.  Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population-Based Study , 1995, Annals of Internal Medicine.

[29]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[30]  J. Dayer,et al.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[31]  B. Bengtsson,et al.  Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. , 1989, BMJ.

[32]  B. McManus,et al.  Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations. , 1986, The American journal of medicine.

[33]  J. Robinson,et al.  Giant-cell Arteritis of the Legs , 1955, British medical journal.

[34]  W. Oyen,et al.  Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. , 2004, The American journal of medicine.

[35]  R. Gasser,et al.  Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18fluorodeoxyglucose-positron emission tomography. , 2003, Circulation.

[36]  石守 崇好.  Increased 18F-FDG uptake in a model of inflammation : Concanavalin A-mediated lymphocyte activation , 2003 .

[37]  A. Alavi,et al.  18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.

[38]  P. Goodman,et al.  FDG-PET finding in early-phase Takayasu arteritis. , 1999, Journal of computer assisted tomography.

[39]  A. Bagga,et al.  Large vessel vasculitis , 2009, Pediatric Nephrology.